{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T03:45:05Z","timestamp":1777952705109,"version":"3.51.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T00:00:00Z","timestamp":1655251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T00:00:00Z","timestamp":1655251200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Ratchadaphiseksomphot Fund, Faculty of Medicine, Chulalongkorn University","award":["RA61\/104"],"award-info":[{"award-number":["RA61\/104"]}]},{"DOI":"10.13039\/501100024597","name":"Office of the Permanent Secretary, Ministry of Higher Education, Science, Research and Innovation","doi-asserted-by":"crossref","award":["RGNS 63\u2013159"],"award-info":[{"award-number":["RGNS 63\u2013159"]}],"id":[{"id":"10.13039\/501100024597","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This study aimed to examine, a multifaceted chaperon-like protein exerting anti-inflammatory action, clusterin (CLU), mRNA and protein levels in the systemic and local joint environment of knee osteoarthritis (OA) patients and to determine whether CLU inhibited interleukin (IL)-1\u03b2-induced inflammation in knee OA fibroblast-like synoviocytes (FLSs) through modulating phosphatidylinositol-3-kinase (PI3K)\/Akt signaling pathway. CLU protein and mRNA expressions in the synovium and its protein levels in plasma and synovial fluid of knee OA patients were measured using immunohistochemistry, real-time PCR, and ELISA, respectively. Anti-inflammatory effect of CLU was further elucidated in knee OA FLSs treated with IL-1\u03b2 in the absence or presence of CLU, CLU alone, or PI3K inhibitor (LY294002) along with IL-1\u03b2 and CLU. In a clinical study, compared with knee OA patients without synovitis, CLU protein and mRNA were expressed in the synovium of knee OA patients with synovitis, especially those with high-grade, consistent with analyses of its plasma and synovial fluid levels. CLU mRNA and protein levels were both associated with synovitis severity. An in vitro study uncovered that CLU significantly alleviated IL-1\u03b2-induced overproduction of nitric oxide and IL-6 in knee OA FLSs. Furthermore, CLU significantly attenuated inflammation and extracellular matrix degradation induced by IL-1\u03b2 via down-regulating expressions of <jats:italic>IL-6<\/jats:italic>, nuclear factor kappa B, and matrix metalloproteinase-13. Mechanistically, CLU significantly impeded IL-1\u03b2-induced Akt phosphorylation in knee OA FLSs, in line with addition of LY294002 along with IL-1\u03b2 and CLU. These findings suggest that CLU may have potential as a novel therapeutic target for synovitis and cartilage destruction in knee OA.<\/jats:p>","DOI":"10.1038\/s41598-022-14295-7","type":"journal-article","created":{"date-parts":[[2022,6,15]],"date-time":"2022-06-15T10:03:06Z","timestamp":1655287386000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Clusterin exacerbates interleukin-1\u03b2-induced inflammation via suppressing PI3K\/Akt pathway in human fibroblast-like synoviocytes of knee osteoarthritis"],"prefix":"10.1038","volume":"12","author":[{"given":"Tachatra","family":"Ungsudechachai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sittisak","family":"Honsawek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiraphun","family":"Jittikoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1132-7442","authenticated-orcid":false,"given":"Wanvisa","family":"Udomsinprasert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,15]]},"reference":[{"key":"14295_CR1","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1002\/art.34453","volume":"64","author":"RF Loeser","year":"2012","unstructured":"Loeser, R. F., Goldring, S. R., Scanzello, C. R. & Goldring, M. B. Osteoarthritis: A disease of the joint as an organ. Arthritis Rheum. 64, 1697\u20131707 (2012).","journal-title":"Arthritis Rheum."},{"key":"14295_CR2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.joca.2015.09.010","volume":"24","author":"AM Malfait","year":"2016","unstructured":"Malfait, A. M. Osteoarthritis year in review 2015: Biology. Osteoarthritis Cartilage 24, 21\u201326 (2016).","journal-title":"Osteoarthritis Cartilage"},{"key":"14295_CR3","first-page":"137","volume":"40","author":"H Lund","year":"2008","unstructured":"Lund, H. et al. A randomized controlled trial of aquatic and land-based exercise in patients with knee osteoarthritis. J. . Med. 40, 137\u2013144 (2008).","journal-title":"J. . Med."},{"key":"14295_CR4","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1001\/jama.2018.19319","volume":"320","author":"D Gregori","year":"2018","unstructured":"Gregori, D. et al. Association of pharmacological treatments with long-term pain control in patients with knee osteoarthritis: A systematic review and meta-analysis. JAMA 320, 2564\u20132579 (2018).","journal-title":"JAMA"},{"key":"14295_CR5","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.pop.2013.08.003","volume":"40","author":"RL Taruc-Uy","year":"2013","unstructured":"Taruc-Uy, R. L. & Lynch, S. A. Diagnosis and treatment of osteoarthritis. Prim Care. 40, 821\u2013836 (2013).","journal-title":"Prim Care."},{"key":"14295_CR6","doi-asserted-by":"crossref","unstructured":"Niemelainen, M., Moilanen, T., Huhtala, H., Eskelinen, A. Outcome of knee arthroplasty in patients aged 65 years or less: A prospective study of 232 patients with 2-year follow-up. Scand. J. Surg. 1457496918816918 (2018).","DOI":"10.1177\/1457496918816918"},{"key":"14295_CR7","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1136\/ard.2004.025270","volume":"64","author":"MJ Benito","year":"2005","unstructured":"Benito, M. J., Veale, D. J., FitzGerald, O., van den Berg, W. B. & Bresnihan, B. Synovial tissue inflammation in early and late osteoarthritis. Ann. Rheum. Dis. 64, 1263 (2005).","journal-title":"Ann. Rheum. Dis."},{"key":"14295_CR8","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1016\/j.joca.2012.08.027","volume":"20","author":"BJ de Lange-Brokaar","year":"2012","unstructured":"de Lange-Brokaar, B. J. et al. Synovial inflammation, immune cells and their cytokines in osteoarthritis: A review. Osteoarthritis Cartilage 20, 1484\u20131499 (2012).","journal-title":"Osteoarthritis Cartilage"},{"key":"14295_CR9","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/S0140-6736(14)60802-3","volume":"386","author":"S Glyn-Jones","year":"2015","unstructured":"Glyn-Jones, S. et al. Osteoarthritis. Lancet 386, 376\u2013387 (2015).","journal-title":"Lancet"},{"key":"14295_CR10","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/jcb.24362","volume":"114","author":"J Chen","year":"2013","unstructured":"Chen, J., Crawford, R. & Xiao, Y. Vertical inhibition of the PI3K\/Akt\/mTOR pathway for the treatment of osteoarthritis. J. Cell Biochem. 114, 245\u2013249 (2013).","journal-title":"J. Cell Biochem."},{"key":"14295_CR11","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1186\/s13018-019-1394-4","volume":"14","author":"S Liu","year":"2019","unstructured":"Liu, S. et al. PI3K\/Akt inhibitor partly decreases TNF-\u03b1-induced activation of fibroblast-like synoviocytes in osteoarthritis. J. Orthop. Surg. Res. 14, 425 (2019).","journal-title":"J. Orthop. Surg. Res."},{"key":"14295_CR12","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/S0014-5793(02)02326-8","volume":"513","author":"S Poon","year":"2002","unstructured":"Poon, S., Treweek, T. M., Wilson, M. R., Easterbrook-Smith, S. B. & Carver, J. A. Clusterin is an extracellular chaperone that specifically interacts with slowly aggregating proteins on their off-folding pathway. FEBS Lett. 513, 259\u2013266 (2002).","journal-title":"FEBS Lett."},{"key":"14295_CR13","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1158\/1078-0432.CCR-08-1805","volume":"15","author":"IP Trougakos","year":"2009","unstructured":"Trougakos, I. P. et al. Intracellular clusterin inhibits mitochondrial apoptosis by suppressing p53-activating stress signals and stabilizing the cytosolic Ku70-Bax protein complex. Clin. Cancer Res. 15, 48\u201359 (2009).","journal-title":"Clin. Cancer Res."},{"key":"14295_CR14","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/S0065-230X(09)04008-1","volume":"104","author":"G Falgarone","year":"2009","unstructured":"Falgarone, G. & Chiocchia, G. Chapter 8: Clusterin: A multifacet protein at the crossroad of inflammation and autoimmunity. Adv Cancer Res. 104, 139\u2013170 (2009).","journal-title":"Adv Cancer Res."},{"key":"14295_CR15","doi-asserted-by":"publisher","first-page":"38214","DOI":"10.1074\/jbc.C300252200","volume":"278","author":"G Santilli","year":"2003","unstructured":"Santilli, G., Aronow, B. J. & Sala, A. Essential requirement of apolipoprotein J (clusterin) signaling for IkappaB expression and regulation of NF-kappaB activity. J. Biol. Chem. 278, 38214\u201338219 (2003).","journal-title":"J. Biol. Chem."},{"key":"14295_CR16","doi-asserted-by":"publisher","first-page":"6471","DOI":"10.4049\/jimmunol.177.9.6471","volume":"177","author":"V Devauchelle","year":"2006","unstructured":"Devauchelle, V. et al. Characterization and functional consequences of underexpression of clusterin in rheumatoid arthritis. J. Immunol. 177, 6471 (2006).","journal-title":"J. Immunol."},{"key":"14295_CR17","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/j.1365-2559.2006.02508.x","volume":"49","author":"V Krenn","year":"2006","unstructured":"Krenn, V. et al. Synovitis score: Discrimination between chronic low-grade and high-grade synovitis. Histopathology 49, 358\u2013364 (2006).","journal-title":"Histopathology"},{"key":"14295_CR18","doi-asserted-by":"publisher","first-page":"1557S","DOI":"10.1177\/1947603520958149","volume":"13","author":"T Ungsudechachai","year":"2021","unstructured":"Ungsudechachai, T., Honsawek, S., Jittikoon, J. & Udomsinprasert, W. Clusterin is associated with systemic and synovial inflammation in knee osteoarthritis. Cartilage. 13, 1557S-S1565 (2021).","journal-title":"Cartilage."},{"key":"14295_CR19","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.4049\/jimmunol.166.4.2705","volume":"166","author":"K Aupperle","year":"2001","unstructured":"Aupperle, K. et al. NF-kappa B regulation by I kappa B kinase-2 in rheumatoid arthritis synoviocytes. J. Immunol. 166, 2705\u20132711 (2001).","journal-title":"J. Immunol."},{"key":"14295_CR20","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.bbrc.2007.02.148","volume":"356","author":"V Savkovic","year":"2007","unstructured":"Savkovic, V. et al. Clusterin is protective in pancreatitis through anti-apoptotic and anti-inflammatory properties. Biochem. Biophys. Res. Commun. 356, 431\u2013437 (2007).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"14295_CR21","doi-asserted-by":"publisher","first-page":"S94","DOI":"10.1016\/j.clim.2008.03.263","volume":"127","author":"A Essabbani","year":"2008","unstructured":"Essabbani, A., Chiocchia, G., Mistou, S. & Devauchelle, V. Sa.42. Clusterin role in NF-kB pathway regulation. Clin. Immunol. 127, S94 (2008).","journal-title":"Clin. Immunol."},{"key":"14295_CR22","first-page":"745","volume":"25","author":"E Fandridis","year":"2011","unstructured":"Fandridis, E. et al. Increased expression levels of apolipoprotein J\/clusterin during primary osteoarthritis. In Vivo 25, 745\u2013749 (2011).","journal-title":"In Vivo"},{"key":"14295_CR23","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1186\/s13075-014-0456-6","volume":"16","author":"SY Ritter","year":"2014","unstructured":"Ritter, S. Y. et al. Mass spectrometry assays of plasma biomarkers to predict radiographic progression of knee osteoarthritis. Arthritis Res. Ther. 16, 456 (2014).","journal-title":"Arthritis Res. Ther."},{"key":"14295_CR24","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s12891-018-2179-3","volume":"19","author":"T Kropackova","year":"2018","unstructured":"Kropackova, T. et al. Lower serum clusterin levels in patients with erosive hand osteoarthritis are associated with more pain. BMC Musculoskelet. Disord. 19, 264 (2018).","journal-title":"BMC Musculoskelet. Disord."},{"key":"14295_CR25","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1053\/joca.2001.0475","volume":"9","author":"JR Connor","year":"2001","unstructured":"Connor, J. R. et al. Clusterin expression in adult human normal and osteoarthritic articular cartilage. Osteoarthritis Cartilage 9, 727\u2013737 (2001).","journal-title":"Osteoarthritis Cartilage"},{"key":"14295_CR26","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1152\/physiolgenomics.00095.2010","volume":"44","author":"G Falgarone","year":"2012","unstructured":"Falgarone, G. et al. Implication of clusterin in TNF-alpha response of rheumatoid synovitis: lesson from in vitro knock-down of clusterin in human synovial fibroblast cells. Physiol. Genom. 44, 229\u2013235 (2012).","journal-title":"Physiol. Genom."},{"key":"14295_CR27","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1002\/1529-0131(200108)44:8<1897::AID-ART328>3.0.CO;2-4","volume":"44","author":"PP Tak","year":"2001","unstructured":"Tak, P. P. et al. Inhibitor of nuclear factor \u03baB kinase \u03b2 is a key regulator of synovial inflammation. Arthritis Rheumatol. 44, 1897\u20131907 (2001).","journal-title":"Arthritis Rheumatol."},{"key":"14295_CR28","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1016\/j.biocel.2013.08.018","volume":"45","author":"S Rigoglou","year":"2013","unstructured":"Rigoglou, S. & Papavassiliou, A. G. The NF-kappaB signalling pathway in osteoarthritis. Int. J. Biochem. Cell Biol. 45, 2580\u20132584 (2013).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"14295_CR29","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1002\/jor.24814","volume":"39","author":"C Matta","year":"2021","unstructured":"Matta, C. et al. Clusterin secretion is attenuated by the proinflammatory cytokines interleukin-1\u03b2 and tumor necrosis factor-\u03b1 in models of cartilage degradation. J. Orthop. Res. 39, 1017\u20131029 (2021).","journal-title":"J. Orthop. Res."},{"key":"14295_CR30","first-page":"4737","volume":"16","author":"H Li","year":"2018","unstructured":"Li, H. et al. TNF-\u03b1 increases the expression of inflammatory factors in synovial fibroblasts by inhibiting the PI3K\/AKT pathway in a rat model of monosodium iodoacetate-induced osteoarthritis. Exp. Ther. Med. 16, 4737\u20134744 (2018).","journal-title":"Exp. Ther. Med."},{"key":"14295_CR31","doi-asserted-by":"publisher","first-page":"12851","DOI":"10.1074\/jbc.M800403200","volume":"283","author":"H Ammar","year":"2008","unstructured":"Ammar, H. & Closset, J. L. Clusterin activates survival through the phosphatidylinositol 3-kinase\/Akt pathway. J. Biol. Chem. 283, 12851\u201312861 (2008).","journal-title":"J. Biol. Chem."}],"updated-by":[{"DOI":"10.1038\/s41598-024-63664-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T00:00:00Z","timestamp":1717545600000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-14295-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-14295-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-14295-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T14:08:50Z","timestamp":1717596530000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-14295-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,15]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["14295"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-14295-7","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41598-024-63664-x","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,15]]},"assertion":[{"value":"16 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-024-63664-x","URL":"https:\/\/doi.org\/10.1038\/s41598-024-63664-x","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9963"}}